Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126081621 | 12608162 | 1 | I | 201607 | 20160718 | 20160729 | 20160729 | EXP | US-SHIRE-US201609379 | SHIRE | 66.13 | YR | F | Y | 0.00000 | 20160729 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126081621 | 12608162 | 1 | PS | NATPARA (PARATHYROID HORMONE) | PARATHYROID HORMONE | 1 | Subcutaneous | 50 ?G, 1X/DAY:QD | NY15004DB | 125511 | 50 | UG | SOLUTION FOR INJECTION | QD | |||||
| 126081621 | 12608162 | 2 | SS | SUCRALFATE. | SUCRALFATE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126081621 | 12608162 | 1 | Hypoparathyroidism |
| 126081621 | 12608162 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126081621 | 12608162 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126081621 | 12608162 | Hallucination | |
| 126081621 | 12608162 | Incoherent | |
| 126081621 | 12608162 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126081621 | 12608162 | 1 | 20160608 | 20160723 | 0 |